A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
National Institutes of Health Clinical Center (CC)
Ohio State University Comprehensive Cancer Center
Hackensack Meridian Health
Acerta Pharma BV
Dana-Farber Cancer Institute
University of Washington
H. Lee Moffitt Cancer Center and Research Institute
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Mayo Clinic
Eli Lilly and Company
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Acerta Pharma BV
H. Lee Moffitt Cancer Center and Research Institute
City of Hope Medical Center
Mayo Clinic
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)
City of Hope Medical Center
University of Washington
Thomas Jefferson University
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
City of Hope Medical Center
Center for International Blood and Marrow Transplant Research
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
University of Maryland, Baltimore
City of Hope Medical Center
University of Miami
Masonic Cancer Center, University of Minnesota
Northwestern University
Thomas Jefferson University
Thomas Jefferson University
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Center
City of Hope Medical Center
Ohio State University Comprehensive Cancer Center
Pharmacyclics LLC.
BeiGene
University of Rochester
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Academic and Community Cancer Research United
University of California, San Diego